MCL1 and B-cell chronic lymphocytic leukemia: In contrast, transfection with Mcl-1 siRNA diminished the viability of CLL cells unexposed to ATO to 57.1% (compared to normalized control) (Figure 7E), again reflecting the importance of Mcl-1 in basal cell survival.